Sign inJoin waitlistJoin the waitlist

Andrea Bullock

Assistant Professor in Medicine at Harvard Medical School · Beth Israel Deaconess Medical Center

Credentials: · · · · ·

History

Beth Israel Deaconess Medical Center
Present

Medical Oncology
2007–2009
Internal Medicine
2004–2007
Doctor of Medicine
2000–2004

Research

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Journal of Clinical Oncology · 2020 · 422 citations
HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal…
Journal of Clinical Oncology · 2018 · 407 citations
Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma
JAMA Oncology · 2018 · 195 citations

Brian Wolpin
11 papers
Rebecca Miksad
11 papers
Kimmie Ng
10 papers
Ammar Sarwar
9 papers
Bruno Bockorny
9 papers
Muneeb Ahmed
9 papers
Douglas Rubinson
8 papers
Jeffrey Weinstein
8 papers
JG
Joseph Grossman
8 papers
Michael Curry
7 papers
Nadine Jackson
7 papers
Thomas Abrams
7 papers

Clinical trials

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
Principal investigator · Recruiting · Phase 2
Beth Israel Deaconess Medical Center
2024–2027
Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
Principal investigator · Completed · Phase 2
Beth Israel Deaconess Medical Center
2009–2013
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
Site PI · Recruiting · Phase 2
EXACT Therapeutics AS
2025–2027
Folfox+Irinotecan+Chemort In Esophageal Cancer
Site PI · Recruiting · Phase 2
Massachusetts General Hospital
2021–2027